Moody’s also affirmed Doylestown’s “Baa2” ratings, affecting $60.6 million of rated debt. The rating affirmation is based on several factors, including Doylestown’s strong market position and proactive management team.
The rating revision is based on Doylestown’s recent weaker-than-expected operating performance, which exacerbates its investment losses.
More articles on healthcare finance:
Mercer Health plans $24M expansion
Indiana radiology group selects McKesson for RCM services
5 ways to build your case for inventory management technology
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
